Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Explore how diversified broad market strategies compare to target date funds for retirement. Learn key differences shaping risk, diversification, and long-term growth.
28,533 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Emergence AI ran five 15-day simulations using leading AI agents to test how autonomous systems could govern a synthe...
Bark is shaping its path in a competitive pet market. This guide breaks down what to expect in bark (bark) 2026 earni...
LISC CEO Michael Pugh warns that housing costs outpace wages are widening the affordability gap. The charity-finance ...
Retail investors are watching Walmart+ closely as a potential catalyst for stronger customer loyalty and bigger baske...
Two popular EM ETFs face off: schwab emerging markets ishares and EEM. This guide breaks down costs, performance, and...
XRP spot ETFs have attracted $1.39 billion since their late-2025 debut, beating Solana ETFs at $1.12 billion. The tre...
Demand for reliable baseload power is on the rise, and nuclear energy stands out as a steady option. Here’s why two n...
Youdao is at a crossroads as AI and education tech intersect. This guide breaks down what to expect from youdao (dao)...
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Vitalik Buterin reiterates Ethereum’s neutrality, separating personal views from the protocol. The stance arrives as ...
Crypto markets enter a high-stakes week as policy, inflation, and geopolitics converge. Here are three things that co...